Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib, Pharmaceutics, April 2021, MDPI AG,
DOI: 10.3390/pharmaceutics13050629.
You can read the full text:

Read

Contributors

The following have contributed to this page